|
|
|
Volumn 35, Issue 3 SUPPL. 3, 1998, Pages 22-26
|
|
Clinical challenges in chronic lymphocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
FLUDARABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
MITOXANTRONE;
PREDNISONE;
VINCRISTINE;
B CELL LEUKEMIA;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG RESPONSE;
FATIGUE;
GASTROINTESTINAL TOXICITY;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SPLENECTOMY;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
MITOXANTRONE;
SPLENECTOMY;
VIDARABINE;
|
|
EID: 0031841742
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (12)
|
